FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to experimental neurophysiology, and can be used for modelling a nervous system having reverberation properties, which are ganglions, and for a method for its creation. Model is created from an animal's leech by destroying connective tissue capsules and glial membranes by pronase, wherein cells and fibres in the ganglion are interconnected by means of slot contacts. To create the model, the leech's abdominal brain is used, wherein the pronase destroys connective tissue capsules and glial membranes, leaving intact nerve cells connected to each other, and preserving the integrity of the neuronal network function of the leech nervous ganglion.
EFFECT: method provides creating a neurophysiological model of a nervous system having reverberation properties by creating a biological model on a natural nervous structure - a modified nervous abdominal ganglion of a medical leech, including intact nerve cells with processes and tight slot-type contacts (electrical synapses), which connect neurons to each other into single networks.
2 cl, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF MODELLING SYNCYTIAL BONDS BETWEEN CELLS IN VITRO | 2010 |
|
RU2433484C1 |
| METHOD OF PREPARING INVERTEBRATE ANIMAL LIVE NEURON PREPARATION | 0 |
|
SU972311A1 |
| TROPHIC FACTORS FOR STIMULATING NERVOUS SYSTEM REGENERATION | 1995 |
|
RU2157223C2 |
| METHOD OF SPINAL MARROW FUNCTIONAL RECOVERY WITH EXPERIMENTAL SIMULATION OF ENTIRE ANATOMICAL GAP IN ACUTE CONDITION | 2007 |
|
RU2341830C1 |
| SUBSTANCE NEUROTROPIC ACTIVITY DETERMINATION METHOD | 0 |
|
SU996910A1 |
| MATRIX FOR CELL TRANSPLANTOLOGY | 2011 |
|
RU2521194C2 |
| PEPTIDE STIMULATING REGENERATION OF CENTRAL NERVOUS SYSTEM NEURONS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR ITS USING | 2006 |
|
RU2301678C1 |
| METHOD OF PRODUCING GLIAL DERIVATIVES OF INDUCED PLURIPOTENT STEM CELLS WITH INCREASED EXPRESSION OF BDNF FOR THERAPY OF ISCHEMIC STROKE | 2023 |
|
RU2829361C1 |
| GENETIC NUCLEOTIDE SEQUENCES OF ARTIFICIALLY MODIFIED GDNF WITH DELETED pro-REGION, PRODUCT OF WHICH HAS IMPROVED PROPERTIES NEURAL INDUCTOR AND STIMULATOR OF FORMATION OF NEURAL PROCESSES, SUITABLE FOR THERAPY OF NEURAL INJURIES, ISCHEMIC STROKES AND NEURODEGENERATIVE DISEASES, EXPRESSION VECTOR, MODIFIED WITH GDNF | 2014 |
|
RU2595377C2 |
| NONCYTOTOXIC SUBSTANCE, METHOD OF REGULATION OF NEUROMEDIATOR OR NEUROMODULATOR RELEASE FROM PRIMARY SENSORY AFFERENT CELLS AND METHOD FOR REGULATION OF NEUROMEDIATOR OR NEOROMODULATOR RELEASE FROM PRIMARY NOCICEPTIVE AFFERENT CELLS | 1996 |
|
RU2165976C2 |
